Interim Report January-September 2010

Interim Report January-September 2010

Highlights during the third quarter

  · The acquisition and consolidation of Aleris for a gross investment
of SEK 2.5 bn. (SEK 1.7 bn. adjusted for the share already owned through
the investment in EQT) added another company with attractive potential
to Investor. With full ownership of the company, Investor has the
possibility to pursue strategic and long-term value creating
initiatives.
  · Investor announced the purchase of an additional 34 percent of the
equity in Mölnlycke Health Care for approximately EUR 510 m. Following
regulatory approval, expected during the fourth quarter, Investor will
own 96 percent of the company, thereby consolidating the entity.
  · Investor Growth Capital holdings ChinaCache and China ITS were
priced for IPOs and subsequently listed on the NASDAQ and Hong Kong
Stock Exchange respectively.

Financial information

  · Net asset value amounted to SEK 152,403 m. (SEK 200 per share) on
September 30, 2010, compared to SEK 142,673 m. (SEK 187 per share) at
year-end 2009, corresponding to a change, with dividend added back, of 9
percent for the first nine months 2010 (22).
  · Consolidated net profit for the period, including unrealized change
in value, was SEK 13,181 m. (SEK 17.32 per share), compared to SEK
26,353 m. (SEK 34.53 per share) for the same period 2009.
  · Core Investments contributed SEK 12,888 m. to growth in net asset
value in the period (28,260). Atlas Copco had the largest positive
impact, SEK 5,712 m., while Saab AB had the largest negative impact, SEK
-342 m.
  · Operating Investments contributed SEK 1,221 m. to net asset value
for the period (-1,017).
  · Private Equity Investments contributed SEK -437 m. to net asset
value for the period (-1,151).
  · Leverage (net debt/total assets) was 4.7 percent as of September 30,
2010 (0.4).
  · The total return on the Investor share was 6 percent during the
period (13). The total annual return averaged 6 percent over the past
5-year period.

For further information:

Magnus Dalhammar, Investor Relations Manager, Phone 46 8 614 2130, 46 73
524 2130